Fresh2 Group Limited

OTC-FREHY
OTCMKTS
Biological Products, Except Diagnostic Substances
Global Rank
#49225
Country Rank
#6358
Market Cap
44,452
Price
0.0002
Change (%)
0.00%
Volume
301

Fresh2 Group Limited's latest marketcap:

44,452

As of 07/05/2025, Fresh2 Group Limited's market capitalization has reached $44,452. According to our data, Fresh2 Group Limited is the 49225th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 44,452
Revenue (ttm) 2.34 M
Net Income (ttm) -17,178,274
Shares Out 2.22 M
EPS (ttm) -38.77
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 08/15/2025
Market Cap Chart
Data Updated: 07/05/2025

Fresh2 Group Limited's yearly market capitalization.

Fresh2 Group Limited has seen its market value drop from $59.37 M to $44,452 since 2020, representing a total decrease of 99.93% and an annual compound decline rate (CAGR) of 79.72%.
Date Market Cap Change (%) Global Rank
07/05/2025 $44,452 -99.98% 49225
12/23/2024 $1.89 M -85.37% 48185
12/29/2023 $12.91 M 35.27% 46511
12/30/2022 $9.54 M -50.78% 44776
12/31/2021 $19.39 M -67.33% 42755
12/31/2020 $59.37 M 39537

Company Profile

About Fresh2 Group Limited

Fresh2 Group Limited is a biotechnology company specializing in multi-cancer screening and detection solutions. Utilizing advanced cancer differentiation analysis technology, the company provides innovative testing services to corporations and life insurance providers across the People’s Republic of China.

Core Offerings

  • Cancer Screening & Detection: Cutting-edge tests for early cancer identification.
  • Health Services: Comprehensive physical checkup packages.
  • Technology Solutions: Market research, design, coding, development, and testing services.
  • Product Sales: Genetic testing kits and premium skincare products.
  • E-Commerce Platform: Connects food suppliers with supermarkets and restaurants.

Technology & Innovation

The company owns proprietary core technology platforms and is actively engaged in research, development, and distribution of advanced biotech products.

Corporate Background

Formerly known as AnPac Bio-Medical Science Co., Ltd., the company rebranded to Fresh2 Group Limited in April 2023. Founded in 2010, it is headquartered in New York, New York.

Frequently Asked Questions

  • What is Fresh2 Group Limited's (OTC-FREHY) current market cap?
    As of 07/05/2025, Fresh2 Group Limited (including the parent company, if applicable) has an estimated market capitalization of $44,452 USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Fresh2 Group Limited global market capitalization ranking is approximately 49225 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.